WELLS FARGO & COMPANY/MN - ALBANY MOLECULAR RESH INC ownership

ALBANY MOLECULAR RESH INC's ticker is and the CUSIP is 012423AB5. A total of 23 filers reported holding ALBANY MOLECULAR RESH INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ALBANY MOLECULAR RESH INC
ValueSharesWeighting
Q2 2017$2,144,000
+184.0%
1,500,000
+114.3%
0.00%
Q1 2017$755,000
-73.3%
700,000
-68.2%
0.00%
-100.0%
Q4 2016$2,828,000
+9.1%
2,200,0000.0%0.00%0.0%
Q3 2016$2,591,000
-16.1%
2,200,000
-26.7%
0.00%0.0%
Q2 2016$3,090,000
-52.6%
3,000,000
-48.8%
0.00%
-66.7%
Q1 2016$6,516,000
-38.4%
5,860,000
-25.4%
0.00%
-25.0%
Q4 2015$10,585,000
+96.8%
7,860,000
+80.3%
0.00%
+100.0%
Q3 2015$5,378,000
+10656.0%
4,360,000
+12357.1%
0.00%
Q2 2015$50,000
-21.9%
35,000
-30.0%
0.00%
Q1 2015$64,000
+113.3%
50,000
+100.0%
0.00%
Q4 2014$30,00025,0000.00%
Other shareholders
ALBANY MOLECULAR RESH INC shareholders Q4 2015
NameSharesValueWeighting ↓
Birch Grove Capital LP 8,500,000$10,083,0009.46%
Context Capital Management, LLC 6,575,000$7,787,0007.57%
Mohican Financial Management, LLC 4,500,000$5,302,0005.80%
Verition Fund Management LLC 3,000,000$3,549,0000.38%
BASSO CAPITAL MANAGEMENT, L.P. 2,150,000$2,534,0000.37%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 20,000,000$23,642,000,0000.35%
SSI INVESTMENT MANAGEMENT LLC 3,364,000$3,964,0000.35%
WOLVERINE ASSET MANAGEMENT LLC 14,903,000$17,636,0000.26%
CSS LLC/IL 3,700,000$4,370,0000.21%
PALISADE CAPITAL MANAGEMENT, LP 4,582,000$5,424,0000.19%
View complete list of ALBANY MOLECULAR RESH INC shareholders